References
- Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51:55–67
- Lannigan DA. Estrogen receptor phosphorylation. Steroids 2003;68:1–9
- Weigel NL, Moore NL. Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol 2007;21:2311–19
- Gupta N, Grebhardt S, Mayer D. Janus kinase 2 – a novel negative regulator of estrogen receptor α function. Cell Signal 2012;24:151–61
- Kullander K, Klein R. Mechanisms and functions of Eph and Ephrin signalling. Nat Rev Mol Cell Biol 2002;3:475–86
- Campbell TN, Robbins SM. The Eph receptor/Ephrin system: an emerging player in the invasion game. Curr Issues Mol Biol 2008;10:61–6
- Murai KK, Pasquale EB. Eph’ective signaling: forward, reverse and crosstalk. J Cell Sci 2003;116:2823–32
- Chrencik JE, Brooun A, Recht MI, et al. Structure and thermodynamic characterization of the EphB4/EphrinB2 antagonist peptide complex reveals the determinants for receptor specificity. Structure 2006;14:321–30
- Kumar SR, Singh J, Xia G, et al. Receptor tyrosine kinase ephb4 is a survival factor in breast cancer. Am J Pathol 2006;169:279–93
- Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010;10:165–80
- Berclaz G, Flütsch B, Altermatt HJ, et al. Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. Oncol Rep 2002;9:985–9
- Noren NK, Pasquale EB. Paradoxes of the EphB4 receptor in cancer. Cancer Res 2007;67:3994–7
- Balaguer P, Boussioux AM, Demirpence E, Nicolas JC. Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands. Luminescence 2001;16:153–8
- Medunjanin S, Hermani A, De Servi B, et al. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor-α and is involved in the regulation of receptor activity. J Biol Chem 2005;280:33006–14
- Shukla A, Grisouard J, Ehemann V, et al. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Endocr Relat Cancer 2009;16:429–41
- Grisouard J, Medunjanin S, Hermani A, et al. Glycogen synthase kinase-3 protects estrogen receptor-a from proteasomal degradation and is required for full transcriptional activity of the receptor. Mol Endocrinol 2007;21:2427–39
- Steinle JJ, Meininger CJ, Forough R, et al. EphB4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem 2002;277:43830–5
- Chang HL, Sugimoto Y, Liu S, et al. Keratinocyte Growth Factor (KGF) regulates estrogen receptor-alpha expression and cell apoptosis via PI3K/Akt pathway in human breast cancer cells. Anticancer Res 2009;29:3195–205
- Stoica GE, Franke TF, Moroni M, et al. Effect of estradiol on estrogen receptor-a gene expression and activity can be modulated by the ErbB2/PI3-K/Akt pathway. Oncogene 2003;22:7998–8011
- Kato S, Endoh H, Masuhiro Y, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995;270:1491–4
- Gupta N, Schmitt F, Grebhardt S, Mayer D. β-catenin is a positive regulator of estrogen receptor-α function in breast cancer cells. Cancers 2011;3:2990–3001
- Andres AC, Ziemicki A. Eph and ephrin signaling in mammary gland morphogenesis and cancer. J Mammary Gland Biol Neoplasi 2003;8:475–85
- Alarid ET, Bakopoulos N, Solodin N. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 1999;13:1522–34
- Nawaz Z, Lonard MD, Dennis AP, et al. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci 1999;96:1858–62